Press Release
TGaS® Advisors Appoints Anthony Sorce, Vice President, New Business Development and Jeff Wojcik Promoted to Principal to Help Develop Company Strategy
East Norriton, Penn., August 17, 2009 – Anthony Sorce has been appointed Vice President for New Business Development at TGaS® Advisors, a leader in benchmarking and advisory services for the pharmaceutical industry. The company also announced the promotion of Jeff Wojcik to Principal in recognition of the important contributions he has made to the company while serving as Vice President and Management Advisor responsible for a key business segment.
“Our company has experienced steady growth despite the economic environment and we’re delighted to expand the capabilities of our professional team to meet emerging client needs,” said TGaS Advisors Managing Partner Stephen Gerard. “We are adding new clients, offering new solutions and services and providing deeper support to commercial organizations as they strive to navigate the pharmaceutical and broader healthcare landscape.”
Sorce, who formerly was vice president, pharmaceutical sales, Thomson Reuters Healthcare, will be the key driver of new business at TGaS Advisors. He will be responsible for creating strategy and process for overall business development as well as tactical execution while working closely with colleagues who oversee individual solutions. “With his proven ability to develop and implement effective sales and marketing strategies, Anthony will help us anticipate what pharmaceutical companies need to succeed in today’s evolving marketplace,” said Gerard.
“I’m pleased to be part of the innovative team at TGaS Advisors,” said Sorce. “I look forward to working with pharmaceutical companies as they explore ways to adapt to the changes ahead and thrive.” Sorce earned an MBA in marketing at Fairleigh Dickinson University and holds an undergraduate degree in management and industrial relations from Seton Hall University, South Orange, N.J.
In his expanded role, Wojcik will work closely with other partners of TGaS Advisors in mapping the strategic direction of the company and initiating solutions that enable clients to enhance their critical commercial organization functions. He will continue to lead the Sales Operations Practice.
“Jeff has done a tremendous job since joining our company almost three years ago,” said Gerard. “He exemplifies what it means to be part of TGaS Advisors: he works hard, makes smart decisions, demonstrates a passion for customers and he’s a team player.”
Wojcik expressed enthusiasm at the challenge of assuming a more prominent position at TGaS Advisors. “I’m grateful to all my colleagues for placing trust in me and my abilities to help move our company forward.”
About TGaS® Advisors LLC
TGaS Advisors, ranked ninth among health-related companies by the Inc. 500, is the leader in benchmarking and advisory services to the pharmaceutical and biopharmaceutical industry.The TGaS Advisors roster includes nine of the top 10 and the majority of the top 50 pharmaceutical companies with operations in the U.S. market. The firm’s benchmarking and advisory services suite of solutions, PharmaStance®, provides clients with a way to measure where they stand with respect to their organizations and answers the question, “How do other pharmaceutical companies do ‘it’?”® TGaS Advisors is based in East Norriton, Pennsylvania.
- Other 2009:
- TGaS Advisors’ Gerard Featured on Executive Leaders Radio
- TGaS Advisors Hosts Pharma Commercial Operations Summit on 2010 Trends
- TGaS Advisors’ Donna Wray Invited to Present Benchmark Findings and Recommendations on Digital Marketing Issues at DDMAC Hearings
- The Right Skill Sets for Pharma More Critical Than Ever in 2009, According to TGaS Advisors Organizational Career Guide
- TGaS Advisors Sample Accountability Benchmark Shows Stepped-Up Focus on Compliance Operations
- TGaS Advisors Named to Philadelphia 100®
- Brian Deppen Joins TGaS Advisors Managed Markets Practice
- Managed Markets Leaders Identify Most Urgent Concerns
- TGaS Advisors Named to 2009 INC 500/5000, Ranked First in Business Products & Services in the Mid-Atlantic Region
- Commercial Compliance Benchmark Charts Promotional Monitoring by Pharmaceutical Companies
- Critical Job Skills, Career Progression are Key Issues for Sales Ops Leadership
- Taking “Closed Loop” to the Next Level: Re-Imagining Sales and Managed Markets as an Interactive System
- TGaS Advisors Convenes “Mega-Summit” for Pharma Leaders on the Impact of Industry Trends on Commercial Organizations
- FDA Letters Hobble a Favorite Relationship Marketing Tactic of TGaS Advisors Benchmark Companies Page
- TGaS Advisors Analytics Experts Urge Pharma Management Sciences Professionals to Help Shape Industry Future
- TGaS Advisors Appoints Curt Staab Director, Management Advisor, Sales Advisory Practice
- TGaS Advisors Offers Benchmark-based Services to Support Integration Following Recent Wave of Mergers & Acquisitions
- TGaS Advisors Introduces Commercial Compliance Benchmark